Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Lyra Therapeutics, Inc. Lyra Therapeutics Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for LYR-210 for the Treatment of Chronic Rhinosinusitis June 08, 2021 From Lyra Therapeutics, Inc. Via Business Wire Tickers LYRA Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets June 02, 2021 From Lyra Therapeutics, Inc. Via Business Wire Tickers LYRA Lyra Therapeutics to Present at the William Blair 41st Annual Growth Stock Conference June 01, 2021 From Lyra Therapeutics, Inc. Via Business Wire Tickers LYRA Lyra Therapeutics To Present At The Jefferies Virtual Healthcare Conference May 24, 2021 From Lyra Therapeutics, Inc. Via Business Wire Tickers LYRA Lyra Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update May 11, 2021 From Lyra Therapeutics, Inc. Via Business Wire Tickers LYRA Lyra Therapeutics to Present at the BofA Securities 2021 Virtual Health Care Conference May 06, 2021 From Lyra Therapeutics, Inc. Via Business Wire Tickers LYRA Lyra Therapeutics to Report First Quarter 2021 Financial Results and Provide Corporate Update April 27, 2021 From Lyra Therapeutics, Inc. Via Business Wire Tickers LYRA Lyra Therapeutics Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual April 11, 2021 From Lyra Therapeutics, Inc. Via Business Wire Tickers LYRA Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.